Autres langues

17/12 Humanetics Corporation Appoints Timothy E. Morris as Chief Operating Officer
31/07/24 Implementing 10b5-1 Trading Plans After SEC Amendments And Peizer - July 2024
12/07/24 Humanigen, Inc. Went Out of Business
18/06/24 Third Modified Combined Liquidation Plan Approved for Humanigen, Inc.
01/05/24 Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc.
12/04/24 Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc.
08/03/24 Final DIP Financing Approved for Humanigen, Inc.
17/02/24 Motion for Asset Sale Approved for Humanigen, Inc.
13/02/24 Notice for Auction Cancellation Filed by Humanigen, Inc.
25/01/24 Bidding Procedure Approved for Humanigen, Inc.
08/01/24 Taran Therapeutics, Inc. agreed to acquire Assets of Humanigen, Inc. for $20 million.
05/01/24 19 treatment developer Humanigen files for Chapter 11 bankruptcy
04/01/24 Motion for Asset Sale Filed by Humanigen, Inc.
03/01/24 Humanigen, Inc. Filed for Bankruptcy
03/01/24 Interim DIP Financing Approved for Humanigen, Inc.
15/09/23 Xspray Pharma Names Chief Commercial Officer
14/09/23 Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer
09/08/23 CapitalGainesReport: OTC Bounce List (EPAZ, ABML, HGEN, RINO)
28/07/23 Humanigen, Inc.(OTCPK:HGEN) dropped from S&P TMI Index
25/07/23 Sector Update: Health Care Stocks Steady in Late Afternoon Trading
25/07/23 Humanigen Issues 'Going Concern' Warning; Shares Hit 52-Week Low
25/07/23 Humanigen, Inc. Announces Board Changes
25/07/23 Humanigen, Inc.(OTCPK:HGEN) dropped from NASDAQ Composite Index
19/07/23 Exploring Breakthrough Biotech Stocks: ENZC, CYDY, HGEN, HALB
23/06/23 Humanigen, Inc.(NasdaqCM:HGEN) dropped from Russell Microcap Value Index
Aucun résultat pour cette recherche